| 1 |
34647463 | Reactivities of the Front Pocket N-Terminal Cap Cysteines in Human Kinases. | 2022 Jan 27 |
1 |
| 2 |
34896750 | BTK-inhibitor drug covalent binding to lysine in human serum albumin using LC-MS/MS. | 2022 Feb |
3 |
| 3 |
35587148 | Improved Electrophile Design for Exquisite Covalent Molecule Selectivity. | 2022 Jun 17 |
2 |
| 4 |
33663302 | A single-tube multiplex method for monitoring mutations in cysteine 481 of Bruton Tyrosine Kinase (BTK) gene in chronic lymphocytic leukemia patients treated with ibrutinib. | 2021 Aug |
2 |
| 5 |
33807411 | Covalent Cysteine Targeting of Bruton's Tyrosine Kinase (BTK) Family by Withaferin-A Reduces Survival of Glucocorticoid-Resistant Multiple Myeloma MM1 Cells. | 2021 Mar 31 |
2 |
| 6 |
34424317 | Development and characterization of prototypes for in vitro and in vivo mouse models of ibrutinib-resistant CLL. | 2021 Aug 24 |
1 |
| 7 |
34590480 | Modeling the Binding and Conformational Energetics of a Targeted Covalent Inhibitor to Bruton's Tyrosine Kinase. | 2021 Oct 25 |
2 |
| 8 |
29390068 | Evolutionary relationship between the cysteine and histidine rich domains (CHORDs) and Btk-type zinc fingers. | 2018 Jun 15 |
1 |
| 9 |
29631132 | The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review. | 2018 May 10 |
1 |
| 10 |
29851337 | Targeting the C481S Ibrutinib-Resistance Mutation in Bruton's Tyrosine Kinase Using PROTAC-Mediated Degradation. | 2018 Jul 3 |
2 |
| 11 |
30026342 | Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI. | 2018 Dec |
1 |
| 12 |
27282255 | Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant. | 2017 Jan |
1 |
| 13 |
27669440 | From identification of the BTK kinase to effective management of leukemia. | 2017 Apr |
1 |
| 14 |
28034907 | Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia Cells. | 2017 Jul 15 |
4 |
| 15 |
28485044 | A Specific and Covalent JNK-1 Ligand Selected from an Encoded Self-Assembling Chemical Library. | 2017 Jun 16 |
1 |
| 16 |
26629855 | Covalent targeting of acquired cysteines in cancer. | 2016 Feb |
1 |
| 17 |
27148767 | Investigational Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis. | 2016 Aug |
1 |
| 18 |
27641927 | Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms. | 2016 Nov |
2 |
| 19 |
24472371 | Ibrutinib for B cell malignancies. | 2014 Jan 28 |
3 |
| 20 |
24869598 | Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib. | 2014 Jun 12 |
2 |
| 21 |
9891083 | rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases. | 1999 Feb |
1 |
| 22 |
9280283 | Missense mutations affecting a conserved cysteine pair in the TH domain of Btk. | 1997 Aug 18 |
1 |